Clicky

Immunocore Holdings plc(IMCR) News

Date Title
Jun 18 Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma
May 24 Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
May 11 Analysts Have Made A Financial Statement On Immunocore Holdings plc's (NASDAQ:IMCR) First-Quarter Report
May 8 Immunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue Forecasts
May 8 Immunocore reports first quarter financial results and provides a business update
Apr 24 Immunocore announces upcoming presentation and posters at ASCO 2024
Apr 4 Immunocore to present at upcoming investor conferences
Mar 13 Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
Mar 5 Immunocore presented two posters at CROI 2024
Jan 10 Best Momentum Stocks to Buy for January 10th
Jan 10 Should You Buy Immunocore Holdings PLC Sponsored ADR (IMCR) After Golden Cross?
Jan 5 Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
Jan 3 Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
Dec 31 An Intrinsic Calculation For Immunocore Holdings plc (NASDAQ:IMCR) Suggests It's 50% Undervalued
Dec 18 Immunocore Holdings PLC Sponsored ADR (IMCR) Upgraded to Buy: Here's What You Should Know
Nov 30 Levicept Appoints Eliot Forster as CEO
Nov 27 Can Immunocore Holdings PLC Sponsored ADR (IMCR) Climb 75.55% to Reach the Level Wall Street Analysts Expect?
Jul 18 Immunocore Holdings (NASDAQ:IMCR) shareholders have earned a 41% return over the last year
Jun 7 With 45% stake, Immunocore Holdings plc (NASDAQ:IMCR) seems to have captured institutional investors' interest